Royal Sense Limited
BSE: ROYAL · Medical Equipment & Supplies · sector
Key numbers
Last 12 months to Mar 2026, Consolidated. "Sector median" = middle value of 15 companies in Medical Equipment & Supplies (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Operating profit covered interest 10.4x in the last 12 months.
- Other income was 2% of net profit in the last 12 months.
- No dividend in the last 3 financial years.
- Price ₹68.40 on 2026-10-26: -73.3% from the 52-week high, +3.7% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Revenue | 40 | 43 | 60 |
| EBITDA | 6 | 6 | 5 |
| OPM % | 14.4% | 13.3% | 8.6% |
| Other income | 0 | 0 | 0 |
| Net profit | 4 | 4 | 3 |
| EPS (₹) | 8.07 | 7.63 | 5.83 |
Consolidated figures where filed. Latest quarter Mar 2026.
Profit & loss (yearly)
| ₹ cr | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|
| Revenue | 19 | 62 | 103 | 103 |
| EBITDA | 2 | 9 | 11 | 11 |
| Net profit | 2 | 6 | 7 | 7 |
| EPS (₹) | 3.49 | 12.91 | 13.46 | 13.46 |
| Revenue growth | +225.6% | +67.5% | – | |
| Profit growth | +270.2% | +13.0% | – | |
| Dividend / share (₹) | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | -42.3% (2y) | -69.7% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 21 | 33 |
| Cash & equivalents | 11 | 3 |
| Total assets | 36 | 61 |
| Fixed assets | 2 | 2 |
| Investments | 0 | 0 |
| Inventory | 6 | 14 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 1 | -13 |
| Cash from investing | -2 | -0 |
| Cash from financing | 3 | 5 |
| Capex | 2 | 0 |
| Free cash flow | -0 | -13 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 30.7% | 21.9% |
| ROCE % | 43.4% | 33.7% |
| Inventory days | 42 | 63 |
| Working capital days | 152 | 136 |
Peers in Medical Equipment & Supplies
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| POLYMED | ₹14,631 cr | 46.4x | 4.7x | 10.7% | 12.7% | 22.8% | +18.9% | 0.24% |
| MOLBIO | ₹14,360 cr | – | – | – | – | – | – | – |
| TARSONS | ₹1,587 cr | 142.7x | 2.5x | 1.8% | 4.1% | 26.8% | +14.3% | – |
| LAXMIDENTL | ₹945 cr | 30.4x | 3.9x | 13.7% | 13.4% | 14.0% | – | – |
| FISCHER | ₹856 cr | 11.2x | 2.2x | -0.8% | 11.6% | 13.6% | – | 0.04% |
| HSIL | ₹740 cr | 36.9x | 6.5x | 21.8% | 24.1% | 10.0% | – | – |
| FABTECH | ₹543 cr | 8.8x | 1.3x | 11.6% | 13.6% | 10.9% | – | – |
| PREVEST | ₹455 cr | 14.7x | 4.0x | 29.9% | 36.9% | 34.1% | +12.9% | 0.26% |
| NURECA | ₹296 cr | 63.0x | 1.6x | 2.5% | 5.3% | 3.5% | +9.7% | – |
| ROYAL | ₹37 cr | 5.1x | 1.1x | 26.9% | 33.7% | 10.6% | – | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Medical Equipment & Supplies |
| Sub-industry | Medical Equipment & Supplies |
| Symbol | ROYAL |
| BSE code | 544143 |
| ISIN | INE0QQG01019 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.